Barretts Esophagus With Dysplasia
22
3
4
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.5%
1 terminated out of 22 trials
90.0%
+3.5% vs benchmark
0%
0 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (22)
Endorotor Resection In Refractory Barrett's Dysplasia Patients
Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Evaluation of Tethered Capsule Endomicroscopy as a Screening Tool for Barrett's Esophagus in the Primary Care Setting
Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy
CLUE: CLinical Utility Study of EsoGuard
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus
Complete Resection of Barrett's Esophagus Harboring Neoplasia With Endoscopic Submucosal Dissection.
Lucid Registry Study
Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus
Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC
Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
Characterization of the Neo-squamous Epithelial Barrier
Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)
EMR Versus ESD for Barrett's Neoplasia
Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study